Variant report

Variant	nsv892650
Chromosome Location	chr9:16696187-16950860
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1885)
CpG islands
(count:1100)
Chromatin interactive
region (count:10)
LncRNA
region (count:9)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1885 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr9:16705170-16705700	H1-hESC	embryonic stem cell:	n/a	n/a
2	ATF2	chr9:16809938-16810818	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF2	chr9:16708465-16709294	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF2	chr9:16726542-16727101	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF2	chr9:16809862-16810744	H1-hESC	embryonic stem cell:	n/a	n/a
6	ATF2	chr9:16708535-16709145	H1-hESC	embryonic stem cell:	n/a	n/a
7	ATF3	chr9:16704572-16705732	A549	lung:	n/a	n/a
8	ATF3	chr9:16704594-16705717	A549	lung:	n/a	n/a
9	BACH1	chr9:16810063-16810727	H1-hESC	embryonic stem cell:	n/a	n/a
10	BACH1	chr9:16708624-16709106	H1-hESC	embryonic stem cell:	n/a	n/a
11	BACH1	chr9:16725246-16725293	H1-hESC	embryonic stem cell:	n/a	n/a
12	BACH1	chr9:16870063-16870262	H1-hESC	embryonic stem cell:	n/a	n/a
13	BACH1	chr9:16934628-16934951	H1-hESC	embryonic stem cell:	n/a	n/a
14	BACH1	chr9:16730241-16730320	H1-hESC	embryonic stem cell:	n/a	n/a
15	BACH1	chr9:16934659-16934853	K562	blood:	n/a	n/a
16	BACH1	chr9:16870940-16871146	H1-hESC	embryonic stem cell:	n/a	n/a
17	BCL11A	chr9:16810304-16810595	H1-hESC	embryonic stem cell:	n/a	chr9:16810540-16810549
18	BCL11A	chr9:16810105-16810590	H1-hESC	embryonic stem cell:	n/a	chr9:16810540-16810549
19	BCL3	chr9:16726476-16727092	A549	lung:	n/a	n/a
20	BCL3	chr9:16921833-16922234	A549	lung:	n/a	chr9:16922220-16922229
21	BCL3	chr9:16704567-16705721	A549	lung:	n/a	n/a
22	BCL3	chr9:16726555-16727142	A549	lung:	n/a	n/a
23	BCL3	chr9:16704702-16705796	A549	lung:	n/a	n/a
24	BCL3	chr9:16701219-16701697	A549	lung:	n/a	n/a
25	BRCA1	chr9:16870026-16870092	H1-hESC	embryonic stem cell:	n/a	n/a
26	BRCA1	chr9:16811852-16811881	H1-hESC	embryonic stem cell:	n/a	n/a
27	BRCA1	chr9:16716591-16716814	Hela-S3	cervix:	n/a	n/a
28	BRCA1	chr9:16727204-16727670	Hela-S3	cervix:	n/a	n/a
29	BRCA1	chr9:16704795-16705688	Hela-S3	cervix:	n/a	n/a
30	CEBPB	chr9:16884994-16885796	IMR90	lung:	n/a	chr9:16885528-16885541
31	CEBPB	chr9:16701129-16701829	A549	lung:	n/a	n/a
32	CEBPB	chr9:16850597-16850910	IMR90	lung:	n/a	chr9:16850746-16850757
33	CEBPB	chr9:16868041-16868355	ECC-1	luminal epithelium:	n/a	chr9:16868232-16868241 chr9:16868232-16868243 chr9:16868230-16868241
34	CEBPB	chr9:16807417-16807481	A549	lung:	n/a	chr9:16807445-16807458
35	CEBPB	chr9:16726736-16727088	HepG2	liver:	n/a	chr9:16726904-16726915
36	CEBPB	chr9:16795267-16795668	IMR90	lung:	n/a	n/a
37	CEBPB	chr9:16848154-16848536	ECC-1	luminal epithelium:	n/a	n/a
38	CEBPB	chr9:16813696-16814362	ECC-1	luminal epithelium:	n/a	chr9:16814023-16814036 chr9:16814024-16814035 chr9:16814023-16814036 chr9:16814023-16814034 chr9:16814023-16814036
39	CEBPB	chr9:16868064-16868414	HepG2	liver:	n/a	chr9:16868232-16868241 chr9:16868232-16868243 chr9:16868230-16868241
40	CEBPB	chr9:16709100-16709447	IMR90	lung:	n/a	n/a
41	CEBPB	chr9:16723872-16724111	HepG2	liver:	n/a	n/a
42	CEBPB	chr9:16850629-16850828	H1-hESC	embryonic stem cell:	n/a	chr9:16850746-16850757
43	CEBPB	chr9:16704727-16705606	A549	lung:	n/a	n/a
44	CEBPB	chr9:16704187-16705663	Hela-S3	cervix:	n/a	n/a
45	CEBPB	chr9:16880221-16880332	H1-hESC	embryonic stem cell:	n/a	n/a
46	CEBPB	chr9:16813860-16814193	HepG2	liver:	n/a	chr9:16814023-16814036 chr9:16814024-16814035 chr9:16814023-16814036 chr9:16814023-16814034 chr9:16814023-16814036
47	CEBPB	chr9:16849320-16849487	H1-hESC	embryonic stem cell:	n/a	n/a
48	CEBPB	chr9:16809587-16810668	H1-hESC	embryonic stem cell:	n/a	chr9:16810211-16810224 chr9:16810210-16810227
49	CEBPB	chr9:16873182-16873748	IMR90	lung:	n/a	chr9:16873434-16873445
50	CEBPB	chr9:16727544-16727563	H1-hESC	embryonic stem cell:	n/a	n/a

(count:1100 , 50 per page) page: 1 2 3 4 5 6 7 ... 22

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:16829168-16829218	HRPEpiC	eye:	n/a
2	chr9:16868891-16868941	HRPEpiC	eye:	n/a
3	chr9:16829168-16829218	HRPEpiC	eye:	n/a
4	chr9:16868891-16868941	HRPEpiC	eye:	n/a
5	chr9:16871185-16871235	LNCaP	prostate:	n/a
6	chr9:16870464-16870514	AG04449	skin:	fetal
7	chr9:16870289-16870339	HNPCEpiC	eye:	n/a
8	chr9:16729515-16729565	U87	brain:	n/a
9	chr9:16872192-16872242	HRPEpiC	eye:	n/a
10	chr9:16870091-16870141	ovcar-3	ovarian:	n/a
11	chr9:16704404-16704454	HNPCEpiC	eye:	n/a
12	chr9:16870289-16870339	GM06990	blood:	n/a
13	chr9:16727830-16727880	AoSMC	blood vessel:	n/a
14	chr9:16705212-16705262	SAEC	small airway:	n/a
15	chr9:16871185-16871235	HUVEC	blood vessel:	n/a
16	chr9:16829168-16829218	PrEC	prostate:	n/a
17	chr9:16871185-16871235	HCM	heart:	n/a
18	chr9:16871185-16871235	HRPEpiC	eye:	n/a
19	chr9:16870289-16870339	T-47D	breast:	n/a
20	chr9:16870893-16870943	GM19239	blood:	n/a
21	chr9:16718892-16718942	SK-N-MC	brain:	n/a
22	chr9:16726860-16726910	BJ	skin:	n/a
23	chr9:16870091-16870141	IMR90	lung:	fetal
24	chr9:16872192-16872242	CMK	blood:	n/a
25	chr9:16871106-16871156	BJ	skin:	n/a
26	chr9:16705212-16705262	K562	blood:	n/a
27	chr9:16870289-16870339	HMEC	breast:	n/a
28	chr9:16868891-16868941	PANC-1	pancreas:	n/a
29	chr9:16872192-16872242	ECC-1	luminal epithelium:	n/a
30	chr9:16868891-16868941	LNCaP	prostate:	n/a
31	chr9:16718892-16718942	SK-N-SH_RA	brain:	n/a
32	chr9:16729103-16729153	GM06990	blood:	n/a
33	chr9:16871185-16871235	SK-N-SH_RA	brain:	n/a
34	chr9:16871106-16871156	NT2-D1	testis:	n/a
35	chr9:16729515-16729565	AG04449	skin:	fetal
36	chr9:16872192-16872242	GM19239	blood:	n/a
37	chr9:16727830-16727880	ovcar-3	ovarian:	n/a
38	chr9:16868891-16868941	PrEC	prostate:	n/a
39	chr9:16718892-16718942	SKMC	muscle:	n/a
40	chr9:16864746-16864796	RPTEC	kidney:	n/a
41	chr9:16871106-16871156	T-47D	breast:	n/a
42	chr9:16870464-16870514	HCM	heart:	n/a
43	chr9:16870091-16870141	ProgFib	skin:	n/a
44	chr9:16705212-16705262	Jurkat	blood:	n/a
45	chr9:16875612-16875662	HRCEpiC	kidney:	n/a
46	chr9:16871185-16871235	PANC-1	pancreas:	n/a
47	chr9:16870893-16870943	PANC-1	pancreas:	n/a
48	chr9:16727830-16727880	HL-60	blood:	n/a
49	chr9:16729103-16729153	MCF10A-Er-Src	breast:	n/a
50	chr9:16829168-16829218	SKMC	muscle:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:62609031..62609585-chr9:16704767..16705357,2	Hela-S3	cervix:
2	chr12:52445126..52445753-chr9:16726910..16727745,2	Hela-S3	cervix:
3	chr3:20227400..20228150-chr9:16726744..16727510,2	Hela-S3	cervix:
4	chr7:5569698..5570590-chr9:16726454..16727434,2	Hela-S3	cervix:
5	chr9:16833151..16834904-chr9:16839778..16842584,2	MCF-7	breast:
6	chr9:16704972..16705696-chr9:16726846..16727389,2	Hela-S3	cervix:
7	chr9:16833151..16834904-chr9:16839778..16842584,2	MCF-7	breast:
8	chr6:2765596..2766255-chr9:16738649..16739454,2	MCF-7	breast:
9	chr19:41731896..41732688-chr9:16704803..16705712,2	Hela-S3	cervix:
10	chr6:3068763..3069618-chr9:16726993..16727675,2	Hela-S3	cervix:

(count:9 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CNTLN-2	chr9:16727313-16727522	ENSG00000234779.1
2	lnc-C9orf92-4	chr9:16714816-16714976	NONHSAT130291
3	lnc-CNTLN-2	chr9:16727029-16727104	ENSG00000234779.1
4	lnc-C9orf92-4	chr9:16700753-16700983	uc_252_-
5	lnc-CNTLN-6	chr9:16700753-16700983	uc_252_+
6	lnc-C9orf92-4	chr9:16700841-16700919	NONHSAT130291
7	lnc-C9orf92-5	chr9:16775571-16775843	NONHSAT130296
8	lnc-CNTLN-2	chr9:16726812-16726953	ENSG00000234779.1
9	lnc-C9orf92-4	chr9:16714816-16714976	NONHSAT130290

No data

Variant related genes	Relation type
ENSG00000233551	TF binding region
BNC2	TF binding region
ENSG00000234779	TF binding region
ENSG00000233551	CpG island
BNC2	CpG island
ENSG00000234779	CpG island
ENSG00000173068	chromatin interactions
ENSG00000124535	chromatin interactions
ENSG00000129810	chromatin interactions
ENSG00000133316	chromatin interactions
ENSG00000075624	chromatin interactions
ENSG00000167601	chromatin interactions
ENSG00000123358	chromatin interactions
ENSG00000272277	chromatin interactions

Extended variants
information (count: 12055 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:12055 , 50 per page) page: 1 2 3 4 5 6 7 ... 242

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1888207	chr9:16696187-16696188	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs183411176	chr9:16696199-16696200	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs377574885	chr9:16696273-16696274	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs369035629	chr9:16696328-16696329	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs186224738	chr9:16696367-16696368	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs529186795	chr9:16696386-16696387	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs145719839	chr9:16696400-16696401	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs545363575	chr9:16696406-16696407	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs549216922	chr9:16696449-16696450	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs528173791	chr9:16696460-16696461	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs148893245	chr9:16696463-16696464	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs35348629	chr9:16696472-16696473	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs528276607	chr9:16696474-16696475	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs190686603	chr9:16696482-16696483	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs551528208	chr9:16696484-16696485	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs529419377	chr9:16696500-16696501	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs10738446	chr9:16696510-16696511	Weak transcription Enhancers Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
18	rs569544771	chr9:16696517-16696518	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs539869115	chr9:16696526-16696527	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs182896574	chr9:16696560-16696561	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs558168356	chr9:16696606-16696607	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs10733316	chr9:16696626-16696627	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs556691906	chr9:16696659-16696660	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs534299554	chr9:16696660-16696661	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs555533547	chr9:16696692-16696693	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs188237699	chr9:16696705-16696706	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs567206791	chr9:16696772-16696773	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs114856207	chr9:16696786-16696787	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs556856137	chr9:16696790-16696791	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs192954023	chr9:16696793-16696794	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs373502539	chr9:16696810-16696811	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs545428318	chr9:16696833-16696834	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs564099581	chr9:16696841-16696842	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs143606512	chr9:16696883-16696884	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs137973707	chr9:16696918-16696919	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs142559024	chr9:16696920-16696921	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs529513224	chr9:16696923-16696924	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs555992783	chr9:16696960-16696961	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs182880465	chr9:16696989-16696990	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs563209529	chr9:16697047-16697048	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs533660354	chr9:16697081-16697082	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs551849318	chr9:16697087-16697088	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs566863967	chr9:16697122-16697123	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs533902626	chr9:16697127-16697128	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs371005407	chr9:16697130-16697131	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs187995759	chr9:16697154-16697155	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs567623967	chr9:16697162-16697163	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs144820449	chr9:16697173-16697174	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs575306004	chr9:16697202-16697203	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs556719224	chr9:16697227-16697228	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Glioblastoma multiforme	18628472	CNVD
Breast cancer	21611746	CNVD
Pancreatic cancer	21811587	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Breast cancer	21364760	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Schizophrenia	23813976	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:3858 , 50 per page) page: 1 2 3 4 5 6 7 ... 78

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:16665000-16704400	Weak transcription	Aorta	Aorta
2	chr9:16679800-16704000	Weak transcription	HSMMtube	muscle
3	chr9:16680000-16704600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
4	chr9:16688200-16700400	Weak transcription	HSMM	muscle
5	chr9:16689800-16699200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr9:16690000-16701000	Weak transcription	Muscle Satellite Cultured Cells	--
7	chr9:16690000-16702400	Weak transcription	HUES6 Cell Line	embryonic stem cell
8	chr9:16690000-16704200	Weak transcription	H1 Cell Line	embryonic stem cell
9	chr9:16690000-16704800	Weak transcription	H9 Cell Line	embryonic stem cell
10	chr9:16690200-16702000	Weak transcription	NH-A	brain
11	chr9:16690400-16701000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
12	chr9:16690400-16703800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr9:16690600-16702200	Weak transcription	NHLF	lung
14	chr9:16691000-16701400	Weak transcription	Osteobl	bone
15	chr9:16691000-16704800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
16	chr9:16691000-16708400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
17	chr9:16693600-16699000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
18	chr9:16693600-16704600	Weak transcription	Fetal Muscle Leg	muscle
19	chr9:16694000-16699000	Weak transcription	Colon Smooth Muscle	Colon
20	chr9:16694200-16701000	Weak transcription	HUVEC	blood vessel
21	chr9:16694600-16700200	Weak transcription	Fetal Stomach	stomach
22	chr9:16694600-16701400	Weak transcription	Fetal Lung	lung
23	chr9:16694800-16703600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
24	chr9:16694800-16704000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
25	chr9:16695000-16699000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
26	chr9:16695000-16701200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
27	chr9:16695200-16699200	Weak transcription	A549	lung
28	chr9:16695200-16702000	Weak transcription	HUES48 Cell Line	embryonic stem cell
29	chr9:16695200-16704000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
30	chr9:16696000-16696400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr9:16696000-16697200	Enhancers	Ovary	ovary
32	chr9:16696000-16698400	Strong transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr9:16696400-16696600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
34	chr9:16696600-16698800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr9:16697200-16701600	Weak transcription	Ovary	ovary
36	chr9:16697600-16704800	Weak transcription	Esophagus	oesophagus
37	chr9:16698400-16699200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
38	chr9:16698800-16700000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr9:16699000-16699400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
40	chr9:16699000-16700000	Enhancers	Colon Smooth Muscle	Colon
41	chr9:16699000-16701000	Genic enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
42	chr9:16699000-16701000	Weak transcription	Fetal Brain Male	brain
43	chr9:16699200-16699400	Enhancers	Rectal Smooth Muscle	rectum
44	chr9:16699200-16699400	Enhancers	Hela-S3	cervix
45	chr9:16699200-16699600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
46	chr9:16699200-16699600	Enhancers	Duodenum Smooth Muscle	Duodenum
47	chr9:16699200-16699800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
48	chr9:16699200-16701200	Enhancers	A549	lung
49	chr9:16699400-16700200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
50	chr9:16699400-16700400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links